Projects per year
Fingerprint Dive into the research topics where Haidong M Dong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 15 Similar Profiles
T-Lymphocytes
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Renal Cell Carcinoma
Medicine & Life Sciences
Immunotherapy
Medicine & Life Sciences
Dendritic Cells
Medicine & Life Sciences
Immunity
Medicine & Life Sciences
B7 Antigens
Medicine & Life Sciences
Ligands
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2008 2019
- 4 Finished
A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR
Park, S., Dong, H. M. & Park, S. S.
2/9/16 → 1/31/19
Project: Research project
Castration
Prostatic Neoplasms
Radiotherapy
Choline
Immunity
Role of Bim and soluble B7-H1 in monitoring T cell responses to anti-PD-1 therapy in melanoma
Dong, H. M., Dronca, R. & Dronca, R. S.
8/17/15 → 7/31/17
Project: Research project
Melanoma
T-Lymphocytes
Therapeutics
Neoplasms
Biomarkers
T-Lymphocytes
Antibodies
Immunotherapy
Neoplasms
Kidney Neoplasms
Clinical Impact of B7-H Immune Cell Coregulators in Renal Cell Carcinoma
12/1/08 → 12/31/15
Project: Research project
Renal Cell Carcinoma
Ligands
Neoplasms
Cellular Immunity
Patient Care
Research Output 1992 2019
1
Citation
(Scopus)
Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy
Failing, J. J., Dudek, O. A., Marin Acevedo, J. A., Chirila, R. M., Dong, H. M., Markovic, S. N. & Dronca, R. S., Aug 1 2019, In : Future Oncology. 15, 22, p. 2645-2656 12 p.Research output: Contribution to journal › Review article
Biomarkers
Neoplasms
Sample Size
Immunotherapy
Therapeutics
1
Citation
(Scopus)
BRAF V600E-induced, tumor intrinsic PD-L1 can regulate chemotherapy-induced apoptosis in human colon cancer cells and in tumor xenografts
Feng, D., Qin, B., Pal, K., Sun, L., Dutta, S., Dong, H., Liu, X., Mukhopadhyay, D., Huang, S. & Sinicrope, F. A., Jan 1 2019, (Accepted/In press) In : Oncogene.Research output: Contribution to journal › Article
Heterografts
Colonic Neoplasms
Apoptosis
Ligands
Drug Therapy
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels
Sideras, K., de Man, R. A., Harrington, S. M., Polak, W. G., Zhou, G., Schutz, H. M., Pedroza-Gonzalez, A., Biermann, K., Mancham, S., Hansen, B. E., Bart Takkenberg, R., van Vuuren, A. J., Pan, Q., Ijzermans, J. N. M., Sleijfer, S., Sprengers, D., Dong, H. M., Kwekkeboom, J. & Bruno, M. J., Dec 1 2019, In : Scientific reports. 9, 1, 10677.Research output: Contribution to journal › Article
Open Access
Galectins
Hepatocellular Carcinoma
Survival
Liver Transplantation
Biomarkers
Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinoma
Eckel-Passow, J. E., Ho, T. H., Serie, D. J., Cheville, J. C., Houston Thompson, R., Costello, B. A., Dong, H., Kwon, E. D., Leibovich, B. C. & Parker, A. S., Jan 1 2019, (Accepted/In press) In : Cancer medicine.Research output: Contribution to journal › Article
Open Access
Neoplasms
Renal Cell Carcinoma
Clear-cell metastatic renal cell carcinoma
Survival
Biomarkers
Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039] (Heliyon (2018) 4(12), (S2405844018323442), (10.1016/j.heliyon.2018.e01039))
Wu, X., Li, Y., Liu, X., Chen, C., Harrington, S. M., Cao, S., Xie, T., Pham, T., Mansfield, A., Yan, Y., Kwon, E. D., Wang, L. M., Ling, K. & Dong, H. M., Mar 1 2019, In : Heliyon. 5, 3, e01309.Research output: Contribution to journal › Comment/debate
Open Access
Drug Therapy
Neoplasms
corrigendum